Marnie Sironen

Marnie Sironen is an experienced communications professional currently serving as Associate Partner at SenateSHJ since May 2023. Previously, Marnie worked at Roche from July 2017 to April 2023 as International Communications Leader, where Marnie led global communications for key portfolio products, focusing on integrated communications for Alzheimer’s disease, Huntington’s disease, Neuromyelitis Optica Spectrum Disorder, and Autism spectrum disorder. Marnie also contributed to communications for significant advancements in Spinal Muscular Atrophy and gene therapy for Duchenne Muscular Dystrophy. Prior to Roche, Marnie held various roles, including Account Director at Virgo Health and Consultant at SenateSHJ. Marnie earned a Bachelor of Arts in Media & Communications from the University of Sydney between 2010 and 2013.